We hope everyone is doing their best to "be well informed about the COVID-19 virus, the disease it causes and how it spreads. Protect yourself and others from infection by washing your hands or using alcohol-based rub frequently and not touching your face." -WHO Affordable at-home COVID-19 testing. Results within minutes. A Leading POCT and IVD Enterprise In China! Attached to the Chinese Academy of Sciences! Quality Comes From Professionalism And Service Makes The Future We have a complete international after-sales processing system and provides 24 hours service. Any more questions please contact me! Covid-19 Antigen Rapid Test Kit (Colloidal gold) Covid-19 IgM/IgG Test Kit (Colloidal gold) Covid-19 IgM/IgG Test Kit (Rare earth nano fluorescence immunochromatography) ISO13485 certified Samples are available At-home testing Results within 15mins Accurate Simple Rapid Authorities approved Monthly productivity 15 million units #AmonMedCAS #ChineseAcademyofSciences #IVD #POCT #PCR #invitrodiagnostic #diagnostics #VdcConnect #healthcare #IgG #IgM #antibody #antigen #coronavirus #covid19 #Covid19testing #pruebacovid #laboratorio #nyccovid #covidathome #conciergetesting #clinical #lab #hospital #testkit #ISO13485 #rapidtest #biotecnologia #quimica #bioquimica
Product Features Easy Shorten window period in Antigen detection Flexible Saliva sample, Nasal/Throat swabs sample, VTM Simple Visual result interpreted, no instrument required Rapid Result interpreted in 15 minutes
Diagnostic Kit for IgM/IgG 2 in 1 Antibody to 2019-nCoV (Colloidal Gold) Test principle This diagnostic kit adopts the principle of colloidal gold immunochromatographic test strip to make qualitative test for 2019-nCoV IgM/IgG antibody in human serum, human plasma and whole blood samples. Purpose This diagnostic kit is used for making qualitative test for 2019-nCoV IgM/IgG antibody in human serum, human plasma and whole blood samples. It acts as an early-stage aided diagnostic kit for clinical patients infecting 2019-nCoV, yet it is not the only standard for clinical diagnose. Sample requirements This kit is suitable for human serum (EDTA anticoagulant, heparin anticoagulant, trisodium citrate dihydrate anticoagulant 1:9), human plasma and whole blood samples.
Purpose This test kit is used for making qualitative test for COVID-19 antigen in human nose swab and throat swab samples. It acts as an early-stage aided diagnostic kit for clinical patients infecting COVID-19, yet it does not stand for the basis for confirming COVID-19. Sample requirements When using sterile swab for collecting samples, polyester sponge swab with PP bar is recommended when collecting nose swab and throat swab. When collecting nose swab, the swab will be gently inserted into the nose palatine and stay for a moment, and then gradually rotate it until it is taken out. When collecting throat swab, the swab will be completely inserted into the throat from the mouth, then inspectors will wipe pharyngeal tonsil on both sides and posterior wall of pharynx with appropriate strength, and finally take the swab out. During this process, please avoid touching the tongue. After collecting the samples, please make processing with viral transport medium or sample diluent provided in the test kit as soon as possible, and complete test within five minutes. Test principle This test kit adopts the principle of high-specificity antigen-antibody reaction and colloidal gold labelling and immunochromatographic test strip techniques. The reagent contains COVID-19-NP antigen monoclonal antibody pre-fixed in film test area and COVID-19-NP antigen monoclonal antibody-colloidal go
hrough market research and government trading department internal documents, we have complied a covid-19 related products suppliers contract info. The data consists of product introduction (including description and certification) and main markets they export. Supplier�¢??s name and contact person phone number. All the contract person are the one who directly responsible for international selling, and the phone number is her/his direct mobile phone. 100% accurate and updated at the end of March 2020 The data consists of 6 categories 1. Diagnostic reagent supplier (eg. Covid-19 test kit etc.) 2. Medical equipment (like ventilators etc.) supplier 3. Chinese patent medicine supplier 4. AI-aid diagnostic system supplier 5. Temperature measuring device supplier (eg. Thermometer etc.) 6. Disinfection equipment (eg irradiation system and disinfection gel, hand wash etc.) 7. Protective clothing Each categories price: USD 100 Full package of seven categories: USD: 600
Coronavirus Ag Rapid Test Cassette (Swab) have been placed on the European Market, based on the following performance characteristics (which are also included in the IFU included in each test kit) Coronavirus Ag Rapid Test Cassette (Swab) Method Coronavirus Ag Rapid Test Cassette Total Results Relative Sensitivity: 86.7% Relative Specificity: 100% Accuracy: 96.3% Coronavirus Ag Rapid Test Cassette (Swab) The CE mark has been applied as the products fit the definition of an in vitro diagnostic medical device as defined in the IVD Directive and are classified as a general IVD products as they are not included in List A or List B, and they are not intended to be used by lay users. Please note that this
Test kits , gloves , mask.
CoVirion-CV19-2 SARS-CoV-2 OneStep RT-PCR kit is a probe-based Real Time PCR test designed for the qualitative detection of SARS-CoV-2 Coronavirus, the etiological agent of COVID-2019. It is used to detect N-gene and S-gene in viral RNA.
Co-virion Rapid Antigen Test is an immunochromatographic test designed to qualitatively detect SARS-CoV- 2 antigen in nasopharyngeal geal swab specimens. It is intended to aid in the rapid diagnosis of SARS-CoV-2 infections. Co-virion Rapid Antigen Test is an immunochromatographic test designed to detect the nucleocapsid protein of SARS-CoV-2 in nasopharyngeal swabs (NP). The test strip contains colloidal-gold conjugated particles with monoclonal antibodies against the nu- cleo- capsid protein of SARS-CoV-2. The capture antibodies for nucleocapsid protein of SARS-CoV-2 are coated on the nitrocellulose membrane. When the sample is applied to the sample window (S well), the conjugates dried in the reagent pad are dissolved and migrate along with the sample. If SARS-CoV-2 is present in the sample, a complex formed between the anti-SARS-CoV-2 conjugate and the virus will be captured by the specific an- ti-SARS-CoV-2 monoclonal antibodies coated on the test line region (T), which develops a red line in T region. Presence of T line indicates a positive result. There is also an internal control line to check the accuracy of the test performance. The control line is coated with goat anti-Rabbit IgG antibody which binds to the gold labeled antibody. Failure to form C line confirms the incorrect procedural technique.
Cov-inu RT-PCR kit is a probe based Real Time PCR test designed for the qualitative de- tection of SARS-CoV-2 Coronavirus, the etiological agent of COVID-2019 and A + B Group Inuenza virus (orthomyxovirus). It is used to detect S- M2 ve NS1 genes in viral RNA. Description of the Kit Cov-inu RT PCR Kit is a multiplex PCR kit that is used for the simultaneous detection of COVID-19 agent SARS-COV-2 and Inuenza A and Inuenza B viruses from the same sample. Coronaviruses are a large family of viruses that cause infections in humans and other mammals (such as camels, cats, dogs, and bats). The SARS-CoV-2 virus is a new coronavirus that was identified by the World Health Organization (WHO) (1) on February 11, 2020. Inuenza is caused by three types of immunological RNA viruses (A, B and C) in the Orthomyxoviridae family. Seasonal inuenza is typically caused by three main hem- agglutinin subtypes (H1, H2, and H3) and two neuraminidase subtypes (N1 and N2). It is important that public health laboratories around the world conduct detailed surveillance to monitor the spread and impact of the pandemic H1N1 2009 virus, as well as predict future changes in virulence (4). Therefore, methods for rapid diagnosis, case detection and follow-up of this new pathogen in the human population are necessary to develop appropriate management strategies to reduce morbidity and mortality. The test works with single-stage real time reverse transcriptase polymerase chain reaction (On- eStep RT-PCR) with serum, lower respiratory tract samples (e.g. bronchoalveolar lavage, sputum, tracheal aspirate), and upper respiratory tract samples (e.g. nasopharyngeal uids, nasal swab) from individuals who demonstrate clinical criteria set for COVID-19 by WHO (2) and CDC (Center for Disease Control and Prevention) (3). This kit is an In-vitro diagnostic kit using specific primers designed for qualitative detection of genomic RNAs of SARS-CoV-2, Inuenza A and Inuenza B virus.
Sensitivity: 95.06% Specificity: 99.62% Content of each kit: Test card (innovative and unique system), detailed instructions for use, sterile disposable swab, reactive solution for sample treatment, illustrative manual for use and operation. General characteristics: CE self-diagnostic certification, holographic security label with individual code for authenticity verification, non-invasive, easy to use, no prescription required, rapid results in less than 15 minutes, high precision. Sale restrictions: Exclusive sale to pharmacies, authorized companies, pharmaceutical distribution, socio-sanitary establishments, health establishments, occupational risk prevention, public organizations and health professionals. Restricted sale to individuals. Sale subject to the provisions of Royal Decree 588/2021, of July 20, which modifies Royal Decree 1662/2000, of September 29, on medical devices for "in vitro" diagnosis, in order to regulate the sale to the public and the advertising of covid-19 self-diagnosis products. Sale subject in relation to tax matters to the provisions of Royal Legislative Decree 35/2020, of December 22, seventh final provision. Applicable tax rate of Value Added Tax to deliveries, imports and intra-community acquisitions of certain goods and provision of services necessary to combat the effects of SARS-CoV-2 as well as for the purposes of the special regime of the equivalence surcharge .
Kit Rapid Test, Hotgen, Clungene, Hightop, Newgene
Bacterial Vaginosis Rapid Test Kit core Chromogenic Ingredient IBX-4041 IBX-4041 Testing vessel BV Blue active ingredient BVBlue active ingredient BVBlue substrates BV Blue substrates Chromogenic substrate IBX-4041 chromogenic substrate of sialidase enzyme Detection reagent for bacterial vaginosis (sialidase two-step method) Shenzhen BST Science & Technology Co., Ltd sells and exports chromogenic substrate of sialidase enzyme IBX-4041. Specification: Appearance: Light yellow solid powder Purity: 95% min Application: Two-step chromogenic substrates of neuraminidase (sialidase) BVBLUE Test Kit Component 1)BVBLUE Developer Solution: Water and Sodium hydroxide 2) BVBLUE Testing Vessel: Water, Potassium acetate, IBX-4041 (chromogenic substrate compound). IBX-4041 is the key ingredient of BVBLUE test kit, BVBLUE test is a rapid sialidase test for bacterial vaginosis. BVBLUE test method is currently the only test method approved by the FDA for testing Bacterial Vaginosis(BV), The BV BLUE Test contains a chromogenic substrate of sialidase enzyme, IBX-4041. BV Blue test is a commercially available test, it detects sialidase activity, an enzyme produced by BV-associated bacteria such as Gardnerella vaginalis, Bacteroides spp., Prevotella spp., and Mobiluncus spp. In the test procedure, a vaginal fluid sample is placed in the test vessel which contains a chromogenic substrate for sialidase. After incubation, a developer solution is added, and If the sample contained a high level of sialidase, a blue or green color is seen. Samples containing no sialidase, or low levels of this enzyme, will generate a yellow color in the reaction. The BV test has high specificity and sensitivity. The BVBlue test enables rapid detection of BV in a physician's office, and can thereby provide advantages over the Amsel methods and other methods requiring extensive laboratory testing. Advantage of BVBLUE Test Kit Compared to other diagnostic test methods for BV such as Amsel criteria, Nugent Gram-stain scoring system, Affirm�® Microbial Identification Test, BVBLUE Test Kit has following advantage: 1, BVBLUE Test is currently the only test method approved by the FDA for testing Bacterial Vaginosis(BV). 2, BVBLUE Test just take 10 minutes to 15 minutes to get the result. 3, High purity sialidase substrate with high specificity can reduce the occurrence of false positive. 4. Comparing with the gold standard, the coincidence rate is high, the relative sensitivity is 93%, and the specificity is 95%. 5. Easy to operate, do not need equipment. 6. The specimen does not need to pretreat.
Real time PCR instrument. With 16-, 48-, or 96- wells. with 4-. 5-. or 6- channels.
Hello My name is Joe President of Blinq Wholesale supplier of Rapid Antigen Covid 19 test. We have 8m IHEALTH test available at our Los Angeles warehouse for $1.90 per test a box and it comes with the 6 month extension on the exp date till Jan 2023 We also have 10m Flowflex At $2.00 Per Box. All Units Are Here In The United States And Ready For Delivery. Price IS Negotiable as your quantity goes up. If you have any questions please email us
REF - L031-11815 Format - Cassette 3.5 mm Finished or Bulk - Finished in kit box Kit Size - 25 Carton Size - 800 pouches (32 kits) Carton Size (mm) - 530*445*410 Gross weight per carton (kg) - 13.2 quantity per carton - 800 Carton # - 1,250.00 Order quantity (pcs) - 1,000,000 Order gross weight (kg) - 16500 Order total volume (cbm) - 120.873
REF - L031-125V5 Format - Cassette 3.5 mm Finished or Bulk - Finished in kit box Kit Size - 5 Carton Size - 600 pouches (120kits) Carton Size (mm) - 520*395*440 Gross weight per carton (kg) - 10.55 quantity per carton - 600 Carton # - 1,666.67 Order quantity (pcs) - 1,000,000 Order gross weight (kg) - 17583 Order total volume (cbm) - 150.627
Covid Test from PXY cooperation with public cooperation, CE certificated. Our products are designated by many European governments. PXY has invested in professional COVID test manufacturers, the COVID test kit we provide, SARS-CoV-2 Antigen Rapid Test Kit, the method used is Colloidal Gold Immunochromatography. Our rapid COVID test kit packed in Card-like format has the following advantage: * Non-invasive. Swabbed specimens from the nasopharynx or oropharyngeal; * Rapid, ONLY in 15 minutes can get the result; * Simple Operation. No more devices required; * High accuracy and stability. Gold-labeled SARS-CoV-2 N protein monoclonal antibodies immobilized on the test area, with corresponding antibodies in the quality control area;
Product Description The iHealth COVID-19 Antigen Rapid Test is a lateral flow assay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2. This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 15 years or older with symptoms of COVID-19 within the first 7 days of symptom onset. This test is also authorized for non-prescription home use with adult-collected nasal swab samples from individuals aged 2 years or older with symptoms of COVID-19 within the first 7 days of symptom onset. This test is also authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 15 years or older, or adult collected anterior nasal swab samples from individuals aged 2 years or older, with or without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests. Pricing: $5.5 PER KIT OF 2 TESTS MOQ: 1 pallet: 84 cartons / 7560 boxes / 15,120 tests Maximum Quantity: Please inquire Shipping Information: 90 Packs per Carton, 2 Tests per Pack 1 pallet: 84 cartons / 7560 boxes 1100 lbs Per pallet Single Package Dimensions (LxWxH) 6.18 x 3.19 x 0.71 Inches Single Package Weight (lb) 0.13 Carton Dimensions (LxWxH) 13.1 x 11.8 x 10.8 Inches Carton Weight (lb) 12.8
Clungene antigen rapid test
